Drug Profile
Research programme: anti-cancer therapeutics - Bantam Pharmaceutical
Alternative Names: BTM 10xxLatest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Bantam Pharmaceutical
- Class Pyrazoles; Pyrroles
- Mechanism of Action Cell cycle inhibitors; KRAS protein modulators; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported B-cell lymphoma; Cancer; Colorectal cancer
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for preclinical development in B-cell lymphoma in USA (PO)
- 28 Feb 2021 No recent reports of development identified for preclinical development in Colorectal-cancer in USA (PO)
- 28 Jan 2021 No recent reports of development identified for preclinical development in Cancer in USA (IV)